Ventas Coverage Assumed by Wells Fargo at Overweight Vs Previous Rating of Equal-Weight
Ventas Analyst Ratings
Wells Fargo Upgrades 3, Downgrades 2 Healthcare REITs on Price to Earnings Growth and Yield
Wells Fargo Upgrades Ventas Inc(VTR.US) to Buy Rating, Raises Target Price to $71
Ventas (VTR) Was Upgraded to a Buy Rating at Wells Fargo
Looking Into Ventas's Recent Short Interest
Mizuho Securities Initiates Ventas Inc(VTR.US) With Buy Rating, Announces Target Price $71
Express News | Ventas Inc : Mizuho Raises Target Price to $71 From $56
Life Science Space Supply Far Outstrips Demand, Fueling Higher Office Vacancy Rates
Ventas Announces $2B Sales Agreement
Express News | Ventas Inc - Entered Into Atm Sales Agreement Relating to Shares of Common Stock Offered by Prospectus Supplement
Express News | Ventas Inc - May Offer and Sell up to $2 Bln Aggregate Gross Sales Price of Common Stock From Time to Time
Ventas Inc To Go Ex-Dividend On October 1st, 2024 With 0.45 USD Dividend Per Share
Ventas Keeps Quarterly Dividend at $0.45 a Share, Payable Oct. 17 to Shareholders of Record Oct. 1
Press Release: Ventas Declares Third Quarter 2024 Dividend of $0.45 Per Common Share
Jefferies Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $73
Jefferies Adjusts Price Target on Ventas to $73 From $66, Maintains Buy Rating
The Analyst Verdict: Ventas In The Eyes Of 7 Experts
Ventas, Kindred Agree to Improve Patient Care, Strengthen Lease
Ventas Is Maintained at Outperform by Evercore ISI Group